ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Neoen SA

Neoen SA (NEOEN)

39.74
-0.08
(-0.20%)
Cerrado 06 Febrero 10:30AM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
39.74
Postura de Compra
39.73
Postura de Venta
39.78
Volume Operado de la Acción
93,510
39.74 Rango del Día 39.81
21.80 Rango de 52 semanas 39.85
Capitalización de Mercado [m]
Precio Anterior
39.82
Precio de Apertura
39.80
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
2,008,725
Acciones en circulación
152,207,004
Rendimiento del Dividendo
0.38%
Ratio Precio/Utilidad
40.27
Beneficio por acción (BPA)
0.99
turnover
646.3M
Beneficio neto
150.2M

Acerca de Neoen SA

Sector
Elec Meas & Test Instruments
Industria
Elec Meas & Test Instruments
Sitio web
Sede
Paris, Paris, Fra
Fundado
-
Neoen SA is listed in the Elec Meas & Test Instruments sector of the Euronext with ticker NEOEN. The last closing price for Neoen was 39.82 €. Over the last year, Neoen shares have traded in a share price range of 21.80 € to 39.85 €.

Neoen currently has 152,207,004 shares in issue. The market capitalisation of Neoen is 6.06 € billion. Neoen has a price to earnings ratio (PE ratio) of 40.27.

NEOEN Últimas noticias

Neoen Selects Doosan to Deliver Largest Standalone Energy Storage System in the Australian Capital Territory

Doosan, a global EPC leader in energy storage, will deploy a lithium-ion battery solution ― bringing grid stability to the backbone of the southern-NSW electricity network. Neoen has named a...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10039.7439.8239.749826239.78643987DE
40.030.075547720977139.7139.8239.7116843739.73475729DE
120.340.86294416243739.439.8539.36200872539.78895946DE
261.443.7597911227238.339.8538.298738639.72036854DE
5213.9854.270186335425.7639.8521.865418438.06136245DE
1569.3230.6377383330.4245.2221.831935036.25870667DE
2609.3930.939044481130.3570.421.826061637.2957758DE

NEOEN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Neoen?
El precio actual de las acciones de Neoen es 39.74 €
¿Cuántas acciones de Neoen están en circulación?
Neoen tiene 152,207,004 acciones en circulación
¿Cuál es la capitalización de mercado de Neoen?
La capitalización de mercado de Neoen es EUR 6.06B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Neoen?
Neoen ha negociado en un rango de 21.80 € a 39.85 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Neoen?
El ratio precio/beneficio de Neoen es 40.27
¿Cuál es el ratio de efectivo a ventas de Neoen?
El ratio de efectivo a ventas de Neoen es 9.36
¿Cuál es la moneda de reporte de Neoen?
Neoen presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Neoen?
El último ingresos anual de Neoen es EUR 646.3M
¿Cuál es el último beneficio anual de Neoen?
El último beneficio anual de Neoen es EUR 150.2M
¿Cuál es la dirección registrada de Neoen?
La dirección registrada de Neoen es 22 RUE BAYARD, PARIS, PARIS, 75008
¿Cuál es la dirección del sitio web de Neoen?
La dirección del sitio web de Neoen es www.neoen.com
¿En qué sector industrial opera Neoen?
Neoen opera en el sector ELEC MEAS & TEST INSTRUMENTS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALCYBCybergun
0.0002 €
(100.00%)
12.48M
MLWEYWeya
0.027 €
(68.75%)
2k
ALENTEntreparticuliersCom
0.75 €
(52.13%)
90.71k
GIM32Gimv NV
0.65 €
(37.71%)
477.35k
ALSASStradim Espac Fin
6.90 €
(33.98%)
2k
CLEXCumulex NV
0.585 €
(-55.68%)
738
SOISOITEC
57.70 €
(-29.72%)
1.92M
TUVDSBio UV Group DS
0.0231 €
(-29.36%)
620.29k
ALALOAcheterLouerFR
0.0227 €
(-29.06%)
2.7M
MLOCTOctopus Biosafety
0.144 €
(-25.39%)
10.36k
ATOAtos SE
0.0021 €
(0.00%)
402.51M
ALVERVergnet
0.0007 €
(-22.22%)
70.45M
BCPBanco Comercial Portugues SA
0.5066 €
(2.76%)
50.03M
INGAING Groep NV
15.92 €
(-0.29%)
22.66M
ALNRGEnergisme SA
0.0037 €
(12.12%)
17.17M
B402 B402 41 segundos hace
Did dems want electric cars? Was anyone producing them in quantity in the us before? Do they compete with some of the fastest cars? As I remember people said it couldn't be done yet........Self driving?

Then on to Reusable rockets? Record number of launches..........World wide intern
rosemountbomber rosemountbomber 45 segundos hace
Raggy, not selling my AMRN as of yet, but looking at targets for a bunch of others that we may havd in common.  Took some off the table in CRMD at 14 and wondering if I should have unloaded all. In CADL and a wee bit apprehensive over the next readout in pancreatic (its a bear) so looking to take so
AMRN BCRX CADL
jog49 jog49 50 segundos hace
I wholeheartedly agree but Golfbum does have the experience. LOL!
FNMA
janice shell janice shell 57 segundos hace
Good. I hope hundreds of thousands more do the same thing.
DewDiligence DewDiligence 1 minuto hace
RANI—The relative bioavailability of oral semaglutide was 107% versus subcutaneous administration. I simply don't believe that statistic is genuine.
capgain capgain 2 minutos hace
That was cool, never seen that before and never heard of the First Edition.
janice shell janice shell 2 minutos hace
No, he did not. And even if he had, that would not have made it okay for Trump to do it.

We do know Trump lied more than 30,000 times during his first term; the Washington Post kept count. I very much doubt that record will ever be broken, except, perhaps, by Trump himself.
Jetmek_03052 Jetmek_03052 2 minutos hace
Nothing to say about the point of my post, little Jimmy boy?

Your compatriot Sylvia just told a bald-faced lie. She basically said that it was OK that POOR WITTLE DBMM was down....because "all the blue chip stocks were down bad this week".

I just proved she was not tel
DBMM
Seminole Red Seminole Red 2 minutos hace
Treasury Secretary Scott Bessent wants to bypass the Fed to lower interest rates

https://www.msn.com/en-us/news/politics/treasury-secretary-scott-bessent-wants-to-bypass-the-fed-to-lower-interest-rates/ar-AA1yygYQ?ocid=msedgntp&pc=HCTS&cvid=9f4f80ffa16d42ce8b5c9382c973dd54&ei=36
I-Glow I-Glow 3 minutos hace
Pillsworth lied about the $20,000 - first he said it was a DTCC Advisory fee - then he said it is a $20,000 MM advisory fee.

It would be illegal for a MM to be paid and the DTCC fees are closer to $2000.

Pillsworth needs to be removed as the CEO.

IG
CCTL
Jim Beem Jim Beem 3 minutos hace
that's called dilution
ASII
docj docj 3 minutos hace
One wonders if CYDY/GSK are in talks:

From doit4dale on Stocktwits. Look at what Emma just said:

Chief Executive Officer (CEO) Emma Walmsley said the company lifted its 2031 estimate as the company is "increasing and prioritizing R&D investment to promising new long-act
CYDY
ITYS ITYS 3 minutos hace
One needs only to chuckle when bashers bring up a P n D, what's in MGON float 250M ?
Now I could see if was a billion shares or 2 billion and most certainly if some ridiculous issued like 5 billion, but 250M ??

C'mon they need to be better ! They are not even being entertaining
MGON
mick mick 3 minutos hace
yes thank you, i was going to thomas
TMaga TMaga 3 minutos hace
The patent was not reinstated and HCMC did not pursue it. They dropped the case against PM and did not reapply to get the patent legal again.
HCMC
splintered sunlight splintered sunlight 4 minutos hace
Incredibly problematic...
ARAT
xxxx xxxx 4 minutos hace
pizza... pizza

we wait

with INTELLIGENT DD

Colorado ?

We can split it,

E/w
N/s

What works?
SHIBUSD
ShawnP123 ShawnP123 4 minutos hace
Many of you will like this if you haven't already been made aware of.
https://www.yahoo.com/finance/video/deepseeks-advanced-tracking-technology-never-222053515.html
NVDA
jimr1717 jimr1717 5 minutos hace
Zzzzz .03, .02, .01, .001
IFUS
rosemountbomber rosemountbomber 6 minutos hace
Capt, I really am not knowledgeable enough to say one way or another and so my thought that it gets denied is a guess.  But what really irks me is the delay.  There is no new information that was discovered since the Fed Appeal decision so this nothing but a delay tactic.  It is one thing for things
AMRN
joe botts joe botts 6 minutos hace
Good one
Calvin Hobbes Calvin Hobbes 6 minutos hace
Yes this is going to a dollar plus very soon. IMHO
MGOL
Louie_Louie Louie_Louie 6 minutos hace
Folks....These appointments and the people involved in re-list/release have been strategically working on this for months and months in the background, hidden away. Trump only needs all his chess pieces in place. Have you noticed how he stirs the pot to misdirect Democrats? While he has those app
urge2surge urge2surge 6 minutos hace
Keep an eye on the dtc vs unrestricted imbalance. He's already used up the previously rescinded shares. Will see if he uses a part of the 2.5 to pay off debts. The current market cap is 480k, minus debts is 250k.
The principal fiduciary duties of a CEO are ROI to shareholders. At current mc,
IDVV

Su Consulta Reciente